Breakthroughs in treatments and medications highlight the annual MauiDerm conference, as well as dozens of sessions and workshops, Q&A with industry leaders, a reception devoted to women in dermatology, and the Alan Shalita Memorial Lecture.
Talk about a sunny reception: Speakers greeted the 350-plus attendees at the latest MauiDerm conference with plenty of good news about breakthroughs in treatment for conditions like psoriasis, melanoma, and atopic dermatitis.
Molecular antibodies in particular were a hot topic at the Grand Wailea Resort in Kihei, Hawaii. “Dermatologists have really entered into a molecular age,” says Dr. George Martin, the Hawaii dermatologist who created MauiDerm and serves as its program director. “These tools are changing patients’ lives and saving their lives in some cases.”
The five-day January program featured dozens of sessions and workshops along with a Q&A featuring the CEOs of Merz USA, Allergan, and Biopelle. “We asked their opinion on all things medical, pharmaceutical, and political,” Martin says. Other highlights included a reception devoted to women in dermatology and the Alan Shalita Memorial Lecture featuring Dr. James Leyden speaking about acne.
Other major topics of discussion at MauiDerm included:
MauiDerm: NP + PA dermatology meetings are planned for this year in Colorado Springs and Washington D.C. MauiDerm for Dermatologists will return to Hawaii in January 2016.
More MauiDerm Coverage
DISCLOSURES for Dr. Martin:
Consultant: Pfizer, DUSA, Valeant
Advisory Boards: Anacor, Abbvie, DUSA, Celgene, LEO, Janssen, Valeant,
Speaker: DUSA, Celgene,LEO, Valeant